However, valsartan no longer had a cardioprotective effect on CHRF overexpression in vivo [78], indicating that valsartan protected against doxorubicin-induced HF in part through a CHRF/TGFβ1 signal pathway [78]. Here, TGFB1 is linked to hydrops fetalis.